​Mid-tier biotech and specialty pharmaceutical firms drive real estate demand (Sponsored content)

Across North America, real estate activity and demand within the life sciences industry seems to have shifted from one driven by big pharma companies to one where mid-tier companies and specialty players are experiencing overnight growth and highly variable needs in response to promising products and treatments...